Skip to main content
ETON logo

ETON · Eton Pharmaceuticals, Inc.

Track ETON — free
$58.86 +18.06 (+44.26%) At close · Aug 14
Market Cap
$1.68B
Shares
28.58M

Options Chain

Underlying $58.86 · at close Aug 14, 2026 Options Calculator

Positioning

Aug 21, 2026 · 4 days to expiry · 38 contracts · mixed snapshot sessions · Feb 26, 2026–Aug 14, 2026; 4 unknown
Put / call OI
dated and unknown snapshot sessions
Open interest
dated and unknown snapshot sessions
Volume
dated and unknown snapshot sessions

Chain

Click any strike for greeks, breakeven and the calculator
OI Vol IV Δ Last Strike Last Δ IV Vol OI
4 4 1031.6% 1 $25.60 0
0 2 1235% 0.994 $13.34 0
0 1021.2% 0.992 -0.011 1105.6% 0
1 5 552.2% 1 $26.90 $0.75 -0.013 945.8% 1 1
2 1 476.3% 1 $11.62 $1.35 -0.015 826.5% 1 1
75 1 407.6% 1 $28.00 $0.35 -0.018 731.5% 1 958
5 4 349.9% 1 $17.83 $0.10 -0.02 652.7% 50 52
8 5 $10.48 $0.10 -0.059 940.4% 10 20
98 4 $35.85 $0.45 -0.026 526.7% 1 3
28 1 $21.01 $0.70 -0.029 474.6% 1 19
52 50 $28.20 $1.23 -0.041 407.1% 500 195
151 2 $21.54 $0.20 -0.044 311.1% 20 78
440 16 $19.50 $0.05 -0.137 401.5% 13 67
559 61 $12.80 $0.10 -0.049 156.6% 39 26
725 66 74.6% 0.98 $7.91 $0.26 -0.131 144.1% 143 84
760 737 93.6% 0.766 $4.72 $1.10 -0.268 112.6% 206 187
18 49 86.1% 0.447 $1.90 $4.25 -0.514 138.5% 7 7
59 88 84.9% 0.159 $0.60 $9.00 -0.813 93.9% 7 1
12 13 107.9% 0.081 $0.25 $13.65 -0.907 112.9% 6 0
About this data

Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Feb 26, 2026–Aug 14, 2026; 4 unknown. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.

In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.

Key facts CIK 1710340 CUSIP 29772L108 13F (30d) 156 filings 154 filers Visit website Investor relations